Table 3. Long-term persistence of RAM.
Sample number | RAM at baseline | Time to Follow-up 1 (months) | RAM at Follow-up 1 | Time to Follow-up 2 (months) | RAM at Follow-up 2 | |
TZ.09.032647 | A98G | 5 | A98G | n.a. | n.d. | |
TZ.08.017184 | M41L | 11 | M41L | 18 | M41L | |
persistent RAM | TZ.08.017176 | M41L | 12 | M41L | 21 | M41L |
TZ.08.017195 | K103N | 13 | K103NS, Y188HY | 18 | K103N | |
TZ.10.003309 | E44D, V118I | 21 | E44D, V118I | n.a. | n.d. | |
TZ.08.029746 | D30N | 12 | none | n.a. | n.d. | |
TZ.09.006017 | V82A | 18 | none | n.a. | n.d. | |
RAM disappeared | TZ.08.022112 | M184I, G190E | 15 | Q151QR | 18 | none |
TZ.09.001336 | G73S | 18 | V179T | n.a. | n.d. | |
TZ.08.023280 | V75A | 12 | T69ST | 14 | T69ST | |
TZ.08.017193 | Y188H | 6 | L10V | n.a. | n.d. | |
TZ.08.022112 | M184I, G190E | 15 | Q151QR | 18 | none | |
TZ.09.001336 | G73S | 18 | V179T | n.a. | n.d. | |
new RAM | TZ.08.023280 | V75A | 12 | T69ST | 14 | T69ST |
TZ.08.017193 | Y188H | 6 | L10V | n.a. | n.d. | |
TZ.08.017195 | K103N | 13 | K103NS, Y188HY | 18 | K103N | |
TZ.08.014495 | M184I | 6 | no PCR product | n.a. | n.d. | |
TZ.09.001323 | G190E, G73S | 18 | no PCR product | n.a. | n.d. | |
unclear | TZ.09.001332 | M184I, K103N | n.a. | n.d. | n.a. | n.d. |
TZ.08.017197 | T215I, K103N, V82T | n.a. | n.d. | n.a. | n.d. | |
TZ.10.002035 | T69N | n.a. | n.d. | n.a. | n.d. |
Of the 16 patients who presented with RAM at baseline, we analyzed plasma specimens collected at later time points (“follow-up 1”, “follow-up 2”) for the presence of RAM. We detected three different scenarios, including persistent RAM, disappearing RAM, and newly emerging RAM (some samples appear in more than one scenario). Time to follow-up sample is indicated in months. In some cases, no PCR product from plasma samples could be generated. The investigation for long-term stability of RAM is insofar incomplete as plasma specimens collected at later time points were not available (“n.a.”) for all patients, referred to as “n.d.” (not determined).